Back to today’s briefing

Story perspectives

Flu and COVID-19 Linked to Cancer Recurrence Risk

8/20/2025

40 3

Summary

Story summary

A study reveals flu and COVID-19 can reactivate dormant cancer cells, heightening recurrence risk.
Inflammation and IL-6 signaling are identified as crucial factors in this reactivation.
Human data indicates COVID-19 may increase cancer mortality risk.
Further research is necessary to assess treatment implications for cancer survivors and the potential benefits of vaccines and anti-inflammatory therapies.

1 of 1

Story summary

A study reveals flu and COVID-19 can reactivate dormant cancer cells, heightening recurrence risk.
Inflammation and IL-6 signaling are identified as crucial factors in this reactivation.
Human data indicates COVID-19 may increase cancer mortality risk.
Further research is necessary to assess treatment implications for cancer survivors and the potential benefits of vaccines and anti-inflammatory therapies.